- Report
- August 2025
- 188 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- November 2025
- 50 Pages
Global
From €2387EUR$2,650USD£2,106GBP
- Report
- November 2025
- 50 Pages
Global
From €2387EUR$2,650USD£2,106GBP
- Report
- October 2025
- 199 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- August 2025
- 183 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- August 2025
- 195 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- August 2025
- 188 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- January 2025
- 200 Pages
Global
From €2243EUR$2,490USD£1,979GBP
- Report
- April 2025
- 200 Pages
Global
From €4045EUR$4,490USD£3,569GBP
- Report
- February 2025
- 200 Pages
Global
From €4045EUR$4,490USD£3,569GBP
- Report
- August 2025
- 191 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- April 2025
- 200 Pages
Global
From €4045EUR$4,490USD£3,569GBP
- Drug Pipelines
- July 2025
- 60 Pages
Global
From €901EUR$1,000USD£795GBP
€1126EUR$1,250USD£994GBP
- Report
- June 2025
- 150 Pages
Global
From €2431EUR$2,699USD£2,145GBP
- Report
- January 2025
- 210 Pages
Global
From €4499EUR$4,995USD£3,970GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2243EUR$2,490USD£1,979GBP
- Report
- November 2024
- 150 Pages
Europe
From €5360EUR$5,950USD£4,729GBP
- Report
- October 2024
- 258 Pages
Global
From €5360EUR$5,950USD£4,729GBP
- Report
- March 2025
- 200 Pages
India
From €2243EUR$2,490USD£1,979GBP
- Report
- March 2024
- 238 Pages
Global
From €5729EUR$6,360USD£5,055GBP
€7161EUR$7,950USD£6,319GBP

Trimethoprim is a urological disorder drug used to treat a variety of urinary tract infections. It is a synthetic antibacterial agent that works by inhibiting the production of dihydrofolic acid, which is necessary for bacterial growth. It is often used in combination with sulfamethoxazole to treat infections caused by bacteria. Trimethoprim is available in both oral and intravenous forms and is generally well tolerated. Common side effects include nausea, vomiting, and diarrhea.
Trimethoprim is a widely used drug in the urological disorder market, as it is effective in treating a variety of urinary tract infections. It is often prescribed in combination with other drugs to treat more severe infections. It is also used to prevent urinary tract infections in patients who are at risk of developing them.
Some companies in the trimethoprim market include Pfizer, Merck, GlaxoSmithKline, and AstraZeneca. Show Less Read more